HDAC9 and cancer: Retinoic acid-related orphan receptor α (RORα)/HDAC-directed inhibition of NF-κB signalling modulates cholesterol metabolism in CD8+ T cells, which may provide a new therapeutic target in cancers such as colon tumours (242).